{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:03:10Z","timestamp":1784815390841,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Spinal Muscular Atrophy (SMA) type 1 is a debilitating condition with a poor prognosis, though therapeutic advances are promising. Long-term ventilation is a common management strategy as respiratory function deteriorates. Without consensus on best practice respiratory management, the decision to initiate invasive LTV (I-LTV) for this group of young children involves many ethical considerations. Understanding the main influencing factors on a clinician's likelihood to initiative I-LTV for a child with chronic critical illness is important to maintain transparency and trust with the family during this challenging time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A factorial survey was used to identify the factors that influence a clinician to support initiation of I-LTV for children with SMA type 1. Factorial survey content was based on literature and evidence-based practice and the content was subject to extensive pretesting and pilot testing. An anonymous survey was disseminated (Oct 2021\u2013Jan 2022), via eight international professional organisations, to clinicians with experience caring for children at the time of initiation of I-LTV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>251 participants answered 514 vignettes on SMA type 1. The greatest influencing factor on clinician's likelihood to initiate I-LTV was parental agreement with the need to initiate I-LTV. Additional qualitative comments from participants support this finding. Clinicians also highlighted the important role of innovative therapies as well as the availability of supports for families when considering initiation however these findings were context based.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The factorial survey approach provides a valuable way of identifying influencers on decision-making in sensitive situations. The findings demonstrate the acceptance of the centrality of parental influence in decisions on care delivery. Effective communication with the child's family is key to ensuring shared understanding and agreement of goals of care. More international research is needed on the long-term effects of novel treatments, as well as impact on quality of life and influence of geographical location, to inform decision-making.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1252440","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T23:53:07Z","timestamp":1698191587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The factorial survey as an approach to investigate clinical decision-making: examining influences on a clinician's decision to initiate life-sustaining clinical technology for a child with spinal muscular atrophy type 1"],"prefix":"10.3389","volume":"11","author":[{"given":"Mary Brigid","family":"Quirke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathal","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nia","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"B1","year":"2022"},{"key":"B2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy\u2014a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/ijms21093297","article-title":"New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era: spinal muscular atrophy","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"key":"B6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.5863\/1551-6776-24.3.194","article-title":"Nusinersen: a novel antisense oligonucleotide for the treatment of spinal muscular atrophy","volume":"24","author":"Neil","year":"2019","journal-title":"J Pediatr Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1177\/10497323221083744","article-title":"The meaning given to bioethics as a source of support by physicians who care for children who require long-term ventilation","volume":"32","author":"Alexander","year":"2022","journal-title":"Qual Health Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/medethics-2020-107099","article-title":"Initiating technology dependence to sustain a child's Life: a systematic review of reasons","volume":"48","author":"Alexander","year":"2022","journal-title":"J Med Ethics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/1094428114547952","article-title":"Best practice recommendations for designing and implementing experimental vignette methodology studies","volume":"17","author":"Aquinis","year":"2014","journal-title":"Org Res Methods"},{"key":"B10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2478\/sjs-2019-0011","article-title":"How factorial survey analysis improves our understanding of employer preferences","volume":"45","author":"McDonald","year":"2019","journal-title":"Swiss J Sociol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12874-022-01653-2","article-title":"Development of a factorial survey for use in an international study examining clinicians\u2019 likelihood to support the decision to initiate invasive long-term ventilation for a child (the TechChild study)","volume":"22","author":"Quirke","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-020-03737-x","article-title":"A systematic concept analysis of \u2018technology dependent\u2019: challenging the terminology","volume":"180","author":"Brenner","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gen Intern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/nur.21768","article-title":"Characteristics of qualitative descriptive studies: a systematic review","volume":"40","author":"Kim","year":"2017","journal-title":"Res Nurs Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2288-9-52","article-title":"Qualitative description\u2014the poor cousin of health research?","volume":"9","author":"Neergaard","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"B16","year":""},{"key":"B17","year":""},{"key":"B18","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.2196\/resprot.7655","article-title":"Addressing participant validity in a small internet health survey (the restore study): protocol and recommendations for survey response validation","volume":"7","author":"Dewitt","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"B19","volume-title":"IBM SPSS statistics for windows, version 28.0","year":"2021"},{"key":"B20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psych"},{"key":"B21","volume-title":"Multilevel modelling of categorical outcomes using IBM SPSS","author":"Heck","year":"2012"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12874-019-0876-8","article-title":"LEVEL (logical explanations & visualizations of estimates in linear mixed models): recommendations for reporting multilevel data and analyses","volume":"20","author":"Monsalves","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/nur.21454","article-title":"A longitudinal study of families with technology-dependent children","volume":"35","author":"Boebel Toly","year":"2012","journal-title":"Res Nurs Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1513\/AnnalsATS.201903-271OC","article-title":"Decisions for long-term ventilation for children. Perspectives of family members","volume":"17","author":"Edwards","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7748\/ncyp.2017.e844","article-title":"Mental health and well-being of parents caring for a ventilator-dependent child","volume":"29","author":"Lee","year":"2017","journal-title":"Nurs Child Young People"},{"key":"B26","year":""},{"key":"B27","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1542\/peds.2013-3608H","article-title":"Tracheostomies and assisted ventilation in children with profound disabilities: navigating family and professional values","volume":"133","author":"Wilfond","year":"2014","journal-title":"Pediatrics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/1367493520961884","article-title":"Approaches to the initiation of life-sustaining technology in children: a scoping review of changes over time","volume":"25","author":"Alexander","year":"2021","journal-title":"J Child Health Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1378\/chest.119.3.940","article-title":"Long-term ventilation for patients with duchenne muscular dystrophy: physicians\u2019 beliefs and practices","volume":"119","author":"Gibson","year":"2001","journal-title":"Chest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"A02200100","DOI":"10.1177\/1060028018789956","article-title":"Nusinersen treatment of spinal muscular atrophy: a systematic review","volume":"67","author":"Albrechtsen","year":"2020","journal-title":"Dan Med J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"NEJM"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"NEJM"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1252440\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T23:53:10Z","timestamp":1698191590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1252440\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":32,"alternative-id":["10.3389\/fped.2023.1252440"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1252440","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"article-number":"1252440"}}